Trust linked to Oscar Health (OSCR) director sells 47,500 shares
Rhea-AI Filing Summary
Oscar Health, Inc. director Mario Schlosser reported trust-related transactions in the company’s common stock. A Pizzo-Schlosser Family Dynasty Trust sold a total of 47,500 shares of Class A common stock in open-market trades at weighted average prices of $29.50, $30.80, and $31.65, pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026.
On the same date, the trust converted 47,500 shares of Class B common stock into 47,500 shares of Class A common stock on a one-to-one basis. After these transactions, the trust holds 43,900 shares of Class A and 538,333 shares of Class B common stock. Schlosser also holds 480,866 Class A and 1,212,293 Class B shares directly, plus additional Class B shares through two other dynasty trusts, and he disclaims beneficial ownership of trust-held shares except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Trust sales and conversions under a pre-set 10b5-1 plan look routine in scale and structure.
The filing shows a Pizzo-Schlosser Family Dynasty Trust selling 47,500 Oscar Health Class A shares in open-market trades while simultaneously converting 47,500 Class B shares into Class A. These are classic paired conversion-and-sale transactions, executed under a Rule 10b5-1 trading plan adopted on March 24, 2026, indicating they were pre-scheduled rather than opportunistic.
Post-transaction, the trust still holds 43,900 Class A and 538,333 Class B shares, and Mario Schlosser has substantial additional direct and indirect Class B holdings convertible into Class A on a one-to-one basis. The footnotes also state he disclaims beneficial ownership of trust-held shares beyond any pecuniary interest. Overall, this appears to be a planned liquidity and diversification move with limited informational value about his view of the stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 47,500 | $0.00 | -- |
| Conversion | Class A Common Stock | 47,500 | $0.00 | -- |
| Sale | Class A Common Stock | 3,600 | $29.50 | $106K |
| Sale | Class A Common Stock | 13,672 | $30.80 | $421K |
| Sale | Class A Common Stock | 30,228 | $31.65 | $957K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026. The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Includes shares to be issued in connection with the vesting of one or more restricted stock units.